[Vibrio vulnificus infections].
Fujiyama
S
S
Tanaka
M
M
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D012621:Seasons; D018805:Sepsis / Q000382:microbiology; D017192:Skin Diseases, Bacterial / Q000382:microbiology; D013754:Tetracyclines; D014733:Vibrio / Q000302:isolation & purification / Q000472:pathogenicity*; D014735:Vibrio Infections / Q000188:drug therapy / Q000382:microbiology
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D013754:Tetracyclines